ThaiVitalis Tech Closes Series A to Accelerate AI Healthcare in Thailand

The company announces an $8M Series A led by a leading Southeast Asian healthcare fund, with proceeds earmarked for R&D and regional expansion.

April 15, 2026, Bangkok — ThaiVitalis Tech today announced the close of an $8 million Series A funding round, led by SEA Health Ventures with participation from existing investor Bangkok Innovation Fund. The capital will be deployed across three strategic priorities: expanding the AI research team, accelerating integration with Thailand's public hospital system, and exploring adjacent Southeast Asian markets (Vietnam, Indonesia).

"Thailand is at a pivotal inflection point in healthcare digitization," said the company's co-founder and CEO. "With a growing elderly population and rebounding medical tourism, the urgency for AI healthcare has never been greater. This funding enables us to bring our technology to more patients and families, faster."

ThaiVitalis Tech currently partners with 8 international hospitals in Bangkok and over 20 community healthcare facilities, serving more than 12,000 patients and monitored residents.